POSA58 Cost-Effectiveness (CE) Analyses for First-Line (1L) Treatment of Advanced or Metastatic Urothelial Carcinoma (MUC): A Systematic Literature Review (SLR)
Abstract
Authors
N Braun P Auti E Arca` S Teitsson E Broughton JR May M Kurt C Alleman